Novo Nordisk Stock Rises on Trial Results for Cagrilintide Obesity Treatment US$ 29.70 Min. order: 1 piece ★★★★★ 4.8 (30 reviews) Sold : Login>>
Based on the early promising data for injectable cagrilintide-semaglutide combination for #obesity #T2D @novonordisk move to test an oral GLP-1 Amylin Amycretin peptide in healthy PPL with overweight and #obesity in P1 US$ 26.42 Min. order: 1 piece ★★★★★ 4.1 (47 reviews) Sold : Login>>
Novo's Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial US$ 29.19 Min. order: 1 piece ★★★★★ 4.5 (114 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 25.11 Min. order: 1 piece ★★★★★ 4.8 (215 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 22.77 Min. order: 1 piece ★★★★★ 4.7 (107 reviews) Sold : Login>>